121 related articles for article (PubMed ID: 23106290)
21. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
Wollina U; Sayer HG; Wollina K; Graefe T
J Dermatol; 2001 Dec; 28(12):734-6. PubMed ID: 11804070
[TBL] [Abstract][Full Text] [Related]
22. Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease.
Allen JA; Greenberg SA; Amato AA
Muscle Nerve; 2009 Oct; 40(4):643-7. PubMed ID: 19670319
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
Leong CF; Cheong SK; Fadilah SA; Ainoon O; Hamidah NH
Med J Malaysia; 2003 Jun; 58(2):229-35. PubMed ID: 14569743
[TBL] [Abstract][Full Text] [Related]
24. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
[No Abstract] [Full Text] [Related]
25. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
[TBL] [Abstract][Full Text] [Related]
26. Esophageal graft-versus-host disease.
Hatcher JL; Wright SC; Lintzenich CR
Ear Nose Throat J; 2013 Feb; 92(2):64. PubMed ID: 23460213
[No Abstract] [Full Text] [Related]
27. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
[TBL] [Abstract][Full Text] [Related]
28. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
Hosseini E; Schwarer AP; Ghasemzadeh M
Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
[TBL] [Abstract][Full Text] [Related]
29. Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.
Terrettaz M; Verholen F; Passweg J; Knipp S; Burkhard PR; Chalandon Y
Bone Marrow Transplant; 2008 Feb; 41(3):315-6. PubMed ID: 17994117
[No Abstract] [Full Text] [Related]
30. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kojima R; Kami M; Kim SW; Murashige N; Kishi Y; Hori A; Imataki O; Hamaki T; Sakiyama M; Masuo S; Fujisawa Y; Makimoto A; Heike Y; Tanosaki R; Takaue Y
Bone Marrow Transplant; 2003 Aug; 32(4):439-42. PubMed ID: 12900783
[TBL] [Abstract][Full Text] [Related]
31. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
Kalaycioglu ME; Bolwell BJ
Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
[TBL] [Abstract][Full Text] [Related]
32. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bogunia-Kubik K; Duda D; Suchnicki K; Lange A
Haematologica; 2006 Dec; 91(12):1628-34. PubMed ID: 17145599
[TBL] [Abstract][Full Text] [Related]
33. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
Sayer HG; Kröger M; Beyer J; Kiehl M; Klein SA; Schaefer-Eckart K; Schwerdtfeger R; Siegert W; Runde V; Theuser C; Martin H; Schetelig J; Beelen DW; Fauser A; Kienast J; Höffken K; Ehninger G; Bornhäuser M;
Bone Marrow Transplant; 2003 Jun; 31(12):1089-95. PubMed ID: 12796788
[TBL] [Abstract][Full Text] [Related]
34. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.
Wiedemann B; Klyuchnikov E; Kröger N; Zabelina T; Stahl T; Zeschke S; Badbaran A; Ayuk F; Alchalby H; Wolschke C; Bokemeyer C; Fehse B; Zander AR; Bacher U
Exp Hematol; 2010 Dec; 38(12):1261-71. PubMed ID: 20851159
[TBL] [Abstract][Full Text] [Related]
35. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilia indicates the evolution to acute graft-versus-host disease.
Basara N; Kiehl MG; Fauser AA
Blood; 2002 Oct; 100(8):3055. PubMed ID: 12382649
[No Abstract] [Full Text] [Related]
37. Isocitrate dehydrogenase inhibitor-driven differentiation may resemble secondary graft failure in post-allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia.
Rasche A; Mason EF; Strickland SA; Byrne M; Ferrell PB
Br J Haematol; 2021 Sep; 194(5):927-931. PubMed ID: 34096047
[No Abstract] [Full Text] [Related]
38. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
[TBL] [Abstract][Full Text] [Related]
39. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
40. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
